Radiation oncology during COVID-19: Strategies to avoid compromised care.
Patrick J HorsleyMichael BackGillian LamouryBrian PorterJeremy BoothThomas N EadePublished in: Asia-Pacific journal of clinical oncology (2020)
The COVID-19 pandemic will present a range of challenges to radiation oncology departments. Early data suggest that cancer patients carry a higher than average, but still low absolute risk of hospitalization from COVID-19. The risk of severe events for those who are hospitalized however, is high. Resources for usual cancer care will likely be limited. Decisions to alter, delay or omit treatment during this period should consider both the risk of the cancer and of COVID-19 to the patient, as well as resource constraints. There is a need for departments to adapt with goals of maintaining an uninterrupted, high quality service and of minimizing compromise to oncologic care.
Keyphrases
- healthcare
- coronavirus disease
- sars cov
- palliative care
- quality improvement
- mental health
- papillary thyroid
- case report
- pain management
- affordable care act
- early onset
- electronic health record
- prostate cancer
- squamous cell
- machine learning
- public health
- combination therapy
- young adults
- childhood cancer
- lymph node metastasis
- catheter ablation
- smoking cessation